Edgewise Therapeutics, Inc.EWTXNASDAQ
LOADING
|||
Switch Symbol:
Net Income Growth Under Pressure
Trending lower.
Left:
||||
Year-over-year net income growth rate
Latest
-12.60%
Near historical average
Average (22q)
-13.05%
Historical baseline
Range
High:11.48%
Low:-74.14%
Volatility
-656.3%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -12.60% |
| Q2 2025 | 11.48% |
| Q1 2025 | -2.86% |
| Q4 2024 | -16.21% |
| Q3 2024 | -8.36% |
| Q2 2024 | -10.42% |
| Q1 2024 | 5.37% |
| Q4 2023 | -17.23% |
| Q3 2023 | -19.77% |
| Q2 2023 | 5.99% |
| Q1 2023 | -17.63% |
| Q4 2022 | -10.96% |
| Q3 2022 | -8.91% |
| Q2 2022 | -9.60% |
| Q1 2022 | -15.47% |
| Q4 2021 | 1.95% |
| Q3 2021 | -25.07% |
| Q2 2021 | -51.91% |
| Q1 2021 | -7.46% |
| Q4 2020 | -74.14% |
| Q3 2020 | 7.89% |
| Q2 2020 | -24.14% |
| Q1 2020 | 0.00% |